Cardiac Rehabilitation for Adults and Adolescents With Congenital Heart Disease Extending Beyond The Typical Patient Population

Cardiac rehabilitation (CR) effectively decreases morbidity and mortality in adults after cardiovascular events.

Lipidomic Profiling Identifies Signatures of Metabolic Risk

Metabolic syndrome (MetS), the clustering of metabolic risk factors, is associated with cardiovascular disease risk.

Type-I Interferons in Atherosclerosis

Cardiovascular diseases (CVDs) are the leading cause of death worldwide

Familial Hypertrophic Cardiomyopathy: Late Potentials and Other Prognostic Markers

Hypertrophic cardiomyopathy (HCM) is an uncommon cardiac condition that has a 1:500 population prevalence and is the most common cause of sudden death in the young, especially in the athletes

Diffuse Myocardial Fibrosis and the Prognosis of Heart Failure with Reduced Ejection Fraction in Chinese Patients: A Cohort Study

Heart failure (HF), a malignant and fatal disease, is a complex clinical syndrome resulting from heart structural remodeling and impaired function in ejecting blood, causing medical and financial burdens worldwide

Long-term Prognostic Impact of Physical Activity in Patients With Stable Coronary Heart Disease

Current European guidelines for management of stable Coronary Heart Disease (CHD) patients recommend to practice a regular physical activity consisting of 30 minutes of moderate-to-vigorous intensity aerobic exercising, at least 3 times a week.